There are some from large clinical lung cancer screening cohorts that show a link between ILA detected in baseline MSCT and all-cause mortality, with a significant number of patients eventually receiving ILD diagnosis [35,36]. This evidence concerns the gene TNFRSF9 and lung carcinoma.